Michael Hummelsberger
Overview
Explore the profile of Michael Hummelsberger including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
6
Citations
55
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Gouriou C, Lemanski C, Pommier P, Le Malicot K, Saint A, Rivin Del Campo E, et al.
Br J Cancer
. 2024 Jan;
130(5):769-776.
PMID: 38184691
Background: Standard care for non-metastatic squamous cell carcinoma of the anus (SCCA) is chemoradiotherapy, data about elderly patients are scarce. Methods: All consecutive patients treated for non-metastatic SCCA from the...
2.
Lallement A, Lamoureux A, Hummelsberger M, Maria A, Meunier L
Clin Res Hepatol Gastroenterol
. 2023 Aug;
47(8):102192.
PMID: 37567465
We report the case of a 63-year-old patient with recurrence of acral malignant melanoma after adjuvant immune checkpoint inhibitors (ICI) treatment by PEMBROLIZUMAB complicated with immune-related grade II hepatitis. Rechallenge...
3.
Vendrely V, Lemanski C, Pommier P, Le Malicot K, Saint A, Rivin Del Campo E, et al.
Radiother Oncol
. 2023 Feb;
183:109542.
PMID: 36813175
Introduction: International guidelines regarding the treatment of squamous cell carcinoma of the anus (SCCA) recommend intensity-modulated radiotherapy (IMRT) combined with mitomycin-based chemotherapy (CT). The French FFCD-ANABASE cohort aimed at evaluating...
4.
Freyer G, Jovenin N, Yazbek G, Villanueva C, Hussain A, Berthune A, et al.
Anticancer Res
. 2012 Dec;
33(1):301-7.
PMID: 23267161
Aim: To carry out a prospective, multicenter and observational study describing prophylactic strategies [cycle delay, dose-reduction, (G-CSF) prescription] to prevent recurrence of neutropenic events (NE) in patients with solid tumors,...
5.
Frelin C, Imbert V, Griessinger E, Peyron A, Rochet N, Philip P, et al.
Blood
. 2004 Sep;
105(2):804-11.
PMID: 15454494
Acute myeloid leukemia (AML) cells are characterized by a constitutive and abnormal activation of the nuclear factor-kappaB (NF-kappaB) transcription factor. This study, conducted in vitro on 18 patients, shows that...
6.
Roth S, Tieulie N, Hummelsberger M, Sanderson F, Heudier P, Fuzibet J
Presse Med
. 2004 Mar;
33(2):102.
PMID: 15026703
No abstract available.